1. 1. Colorectal cancer screening For the purposes of this section, "colorectal cancer screening" means all colorectal cancer examinations and laboratory tests recommended by a health care provider in accordance with the most recently published colorectal cancer screening guidelines of a national cancer society.

   [PL 2019, c. 86, §1 (AMD); PL 2019, c. 86, §10 (AFF).]

2. 2. Required coverage All individual health insurance policies and contracts must provide coverage for colorectal cancer screening for asymptomatic individuals who are:

   1. A. At average risk for colorectal cancer according to the most recently published colorectal cancer screening guidelines of a national cancer society; or

      [PL 2019, c. 86, §2 (AMD); PL 2019, c. 86, §10 (AFF).]

   2. B. At high risk for colorectal cancer.

      [PL 2019, c. 86, §3 (AMD); PL 2019, c. 86, §10 (AFF).]

   [PL 2019, c. 86, §§2, 3 (AMD); PL 2019, c. 86, §10 (AFF).]

3. 3. Billing If a colonoscopy is recommended by a health care provider as the colorectal cancer screening test in accordance with this section and a lesion is discovered and removed during that colonoscopy, the health care provider must bill the insurance company for a screening colonoscopy as the primary procedure. Revisor's Note: §2763. Coverage for medically necessary infant formula (As enacted by PL 2007, c. 595, §2 is REALLOCATED TO TITLE 24-A, SECTION 2764)

   [PL 2007, c. 516, §2 (NEW); PL 2007, c. 516, §5 (AFF).]

RR 2007, c. 2, §11 (RAL). PL 2007, c. 516, §2 (NEW). PL 2007, c. 516, §5 (AFF). PL 2007, c. 595, §2 (NEW). PL 2007, c. 595, §5 (AFF). PL 2019, c. 86, §§1-3 (AMD). PL 2019, c. 86, §10 (AFF).